{"entity":{"id":"nct07007780","kind":"trial","name":"Sacituzumab Tirumotecan in Neoadjuvant Treatment of Early-Stage TNBC","aka":[],"tldr":"A phase 2 trial of sacituzumab tirumotecan in triple-negative breast cancer, run by Xijing Hospital, not yet recruiting.","summary":"Sacituzumab Tirumotecan in Neoadjuvant Treatment of Early-Stage TNBC is a phase 2, interventional study registered as NCT07007780 by Xijing Hospital, with a registry enrolment figure of 35 participants, started 2025-08-20 and due to reach its primary completion in 2026-08-31. Interventions recorded: Sacituzumab Tirumotecan. Conditions listed: Triple -Negative Breast Cancer. Triple-negative eligibility wording from the registry: \"TNBC Confirmation: Confirmed as TNBC based on histology and/or cytology, and meeting the following criteria:\". No results are recorded here; the registry entry is the source.","status":"planned","asOf":"2026-09-24","links":[{"label":"ClinicalTrials.gov NCT07007780","url":"https://clinicaltrials.gov/study/NCT07007780"}],"tags":["ctgov-ingest","tnbc-deep-dive"],"related":[],"cancers":["tnbc-early"],"sections":[],"technologies":["adc"],"targets":[],"drugs":["sacituzumab-tirumotecan"],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT07007780","phase":"2","setting":"A Multicenter, Phase II Clinical Study of Sacituzumab Tirumotecan in Neoadjuvant Treatment of Early-Stage TNBC","sponsor":"Xijing Hospital","enrolled":35,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct07007780/","neighbours":{"cancer":[{"id":"tnbc-early","kind":"cancer","name":"Early triple-negative breast cancer","route":"/cancers/tnbc-early/"}],"technology":[{"id":"adc","kind":"technology","name":"Antibody-drug conjugate (ADC)","route":"/technologies/adc/"}],"drug":[{"id":"sacituzumab-tirumotecan","kind":"drug","name":"Sacituzumab tirumotecan","route":"/drugs/sacituzumab-tirumotecan/"}],"term":[{"id":"tnbc-trials-open-today","kind":"term","name":"Triple-negative breast cancer trials open today (registry snapshot and UK sites)","route":"/terms/tnbc-trials-open-today/"}]}}